These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27789970)

  • 1. Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.
    Finkelstein J; Friedman C; Hripcsak G; Cabrera M
    Pharmgenomics Pers Med; 2016; 9():107-116. PubMed ID: 27789970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential utility of precision medicine for older adults with polypharmacy: a case series study.
    Finkelstein J; Friedman C; Hripcsak G; Cabrera M
    Pharmgenomics Pers Med; 2016; 9():31-45. PubMed ID: 27143951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy.
    Cabrera M; Finkelstein J
    AMIA Jt Summits Transl Sci Proc; 2016; 2016():16-21. PubMed ID: 27570642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.
    Elliott LS; Henderson JC; Neradilek MB; Moyer NA; Ashcraft KC; Thirumaran RK
    PLoS One; 2017; 12(2):e0170905. PubMed ID: 28151991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy.
    Sugarman EA; Cullors A; Centeno J; Taylor D
    Drugs Aging; 2016 Dec; 33(12):929-936. PubMed ID: 27826798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy.
    Brixner D; Biltaji E; Bress A; Unni S; Ye X; Mamiya T; Ashcraft K; Biskupiak J
    J Med Econ; 2016; 19(3):213-28. PubMed ID: 26478982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications.
    Linton A; Bacon TA; Trice S; Devine J; Cottrell L; McGinnis TJ; McAllister EB
    J Manag Care Pharm; 2010 Oct; 16(8):578-92. PubMed ID: 20866163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.
    Qato DM; Wilder J; Schumm LP; Gillet V; Alexander GC
    JAMA Intern Med; 2016 Apr; 176(4):473-82. PubMed ID: 26998708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.
    Campbell NL; Skaar TC; Perkins AJ; Gao S; Li L; Khan BA; Boustani MA
    Clin Interv Aging; 2015; 10():269-75. PubMed ID: 25609939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.
    Jessop JP; Russell J; DeJesus A; Bardolia C; Hanna A; Turgeon J; Michaud V; Amin NS
    Am J Case Rep; 2023 Feb; 24():e938850. PubMed ID: 36804920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.
    Jódar-Sánchez F; Malet-Larrea A; Martín JJ; García-Mochón L; López Del Amo MP; Martínez-Martínez F; Gastelurrutia-Garralda MA; García-Cárdenas V; Sabater-Hernández D; Sáez-Benito L; Benrimoj SI
    Pharmacoeconomics; 2015 Jun; 33(6):599-610. PubMed ID: 25774017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.
    Collins AR; Kung S; Ho JT; Wright JA; Dammen KC; Johnson EK; Lapid MI; Leung JG
    J Psychiatr Res; 2020 Jul; 126():105-111. PubMed ID: 32442780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians.
    Kerr KP; Mate KE; Magin PJ; Marley J; Stocks NP; Disler P; Pond CD
    J Clin Pharm Ther; 2014 Aug; 39(4):383-9. PubMed ID: 24702306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of prescription medications in home-based older adults with stroke: a pilot study.
    Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
    Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.